Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Atzeni

Showing results (291-300 of 395) with videos related to

Pageof 40
Sort By:
Clinical and Experimental Rheumatology|January 9, 2026
Source of vaccine information and trust in health care professionals influence vaccine hesitancy in rheumatology patients in ItalyGiorgia Carrozzo, Marta Colaneri, Maria Vittoria Cossu, et al.
Rheumatology (Oxford, England)|May 26, 2009
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patientsMaurizio Turiel, Fabiola Atzeni, Livio Tomasoni, et al.
Journal of Clinical Medicine|December 23, 2022
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium"Fausto Salaffi, Cesare Siragusano, Alessandra Alciati, et al.
Arthritis and Rheumatism|April 3, 2008
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritisRainer H Straub, Georg Pongratz, Maurizio Cutolo, et al.
Clinical and Experimental Rheumatology|October 5, 2011
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's diseaseFabiola Atzeni, Luigi Boiardi, Davide Nicoli, et al.
Rheumatology (Oxford, England)|September 12, 2012
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's diseaseFabiola Atzeni, Luigi Boiardi, Bruno Casali, et al.
Biologics : Targets & Therapy|April 5, 2016
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumabMaurizio Benucci, Francesca Meacci, Valentina Grossi, et al.
Journal of Clinical Medicine|November 9, 2024
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and DifferencesAndreina Manfredi, Vincenzo Venerito, Massimiliano Cazzato, et al.
Current Rheumatology Reports|January 26, 2021
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory ComponentReuven Mader, Nicola Pappone, Xenofon Baraliakos, et al.
Clinical and Experimental Rheumatology|April 18, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registryMarco Fornaro, Roberto Caporali, Martina Biggioggero, et al.
Pageof 40

Showing results (291-300 of 395) with videos related to

Sort By:
Pageof 40
Clinical and Experimental Rheumatology|January 9, 2026
Source of vaccine information and trust in health care professionals influence vaccine hesitancy in rheumatology patients in ItalyGiorgia Carrozzo, Marta Colaneri, Maria Vittoria Cossu, et al.
Rheumatology (Oxford, England)|May 26, 2009
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patientsMaurizio Turiel, Fabiola Atzeni, Livio Tomasoni, et al.
Journal of Clinical Medicine|December 23, 2022
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium"Fausto Salaffi, Cesare Siragusano, Alessandra Alciati, et al.
Arthritis and Rheumatism|April 3, 2008
Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritisRainer H Straub, Georg Pongratz, Maurizio Cutolo, et al.
Clinical and Experimental Rheumatology|October 5, 2011
PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's diseaseFabiola Atzeni, Luigi Boiardi, Davide Nicoli, et al.
Rheumatology (Oxford, England)|September 12, 2012
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's diseaseFabiola Atzeni, Luigi Boiardi, Bruno Casali, et al.
Biologics : Targets & Therapy|April 5, 2016
Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumabMaurizio Benucci, Francesca Meacci, Valentina Grossi, et al.
Journal of Clinical Medicine|November 9, 2024
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and DifferencesAndreina Manfredi, Vincenzo Venerito, Massimiliano Cazzato, et al.
Current Rheumatology Reports|January 26, 2021
Diffuse Idiopathic Skeletal Hyperostosis (DISH) and a Possible Inflammatory ComponentReuven Mader, Nicola Pappone, Xenofon Baraliakos, et al.
Clinical and Experimental Rheumatology|April 18, 2024
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registryMarco Fornaro, Roberto Caporali, Martina Biggioggero, et al.
Pageof 40